Appco Pharma LLC recalls
2 notices naming Appco Pharma LLC as the recalling firm, since January 29, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Appco Pharma LLC: Prazosin Hydrochloride Capsules and 2 more
Hazard (FDA): cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
FDAMedicines
Appco Pharma LLC: Venlafaxine Extended-Release Tablets
Hazard (FDA): Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
FDAMedicines